Hims & Hers Health, Inc. <HIMS.N>: BofA Global Research raises price objective to $32 from $30
HIMS•Related News
Stratasys - Awarded $7.80 Million Funding Through 2026 America Makes And Department Of War Challenge
SSYS•
SolarMax Technology Announces Reverse Stock Split To Support Effort To Regain Compliance With Nasdaq’s Minimum Bid Price Requirement
SMXT•
Lincoln Electric Americas Welding president Whitehead resigns effective Aug. 28
LECO•
U.S. Stocks on the Move: Duke Energy, Sea, Cardinal Health
SPY•
CleanCore Solutions prices USD 100 million public offering at USD 0.25 per share with warrants
ZONE•